Abstract
Periods of deliberate fasting with restriction of solid food intake are practiced worldwide, mostly based on traditional, cultural or religious reasons. There is large empirical and observational evidence that medically supervised modified fasting (fasting cure, 200-500 kcal nutritional intake per day) with periods of 7-21 days is efficacious in the treatment of rheumatic diseases, chronic pain syndromes, hypertension, and metabolic syndrome. The beneficial effects of fasting followed by vegetarian diet in rheumatoid arthritis are confirmed by randomized controlled trials. Further beneficial effects of fasting are supported by observational data and abundant evidence from experimental research which found caloric restriction and intermittent fasting being associated with deceleration or prevention of most chronic degenerative and chronic inflammatory diseases. Intermittent fasting may also be useful as an accompanying treatment during chemotherapy of cancer. A further beneficial effect of fasting relates to improvements in sustainable lifestyle modification and adoption of a healthy diet, possibly mediated by fasting-induced mood enhancement. Various identified mechanisms of fasting point to its potential health-promoting effects, e.g., fasting-induced neuroendocrine activation and hormetic stress response, increased production of neurotrophic factors, reduced mitochondrial oxidative stress, general decrease of signals associated with aging, and promotion of autophagy. Fasting therapy might contribute to the prevention and treatment of chronic diseases and should be further evaluated in controlled clinical trials and observational studies.
Journal Section:
Review Article <i>· </i> Übersichtsarbeit
References
1.
Mattson M P, Wan R: Beneficial effects of intermittent fasting and caloric restriction on the cardiovascular and cerebrovascular systems. J Nutr Biochem 2005;16:129-137.
[PubMed]
2.
Buchinger O: Das Heilfasten und seine Hilfsmethoden. Stuttgart, Hippokrates, 1932.
3.
Fahrner H: Die Fastenkur. Ärztezeitschrift für Naturheilverfahren 1991;7:544-548.
4.
Lützner H: Fasten. Bindlach, Gondrom, 2002.
5.
Hartel U, Volger E: Inanspruchnahme und Akzeptanz klassischer Naturheilverfahren und alternativer Heilmethoden in Deutschland - Ergebnisse einer repräsentativen Bevölkerungsstudie. Forsch Komplementärmed Klass Naturheilkd 2004;11:327-334.
[PubMed]
6.
Buchinger A: Fasting; in Nowey D (ed): Clinician's Complete Reference to Complementary and Alternative Medicine. Chicago, Mosby, 2002.
7.
Lützner H: Fasten/Fastentherapie: Grundlagen und Methodik; in Bühring M, Kemper FH, Matthiessen PF (eds): Naturheilverfahren und Unkonventionelle Medizinische Richtungen. Berlin, Springer LoseblattSysteme, 1998, pp 1-26.
8.
Buchinger O: 40 years of fasting therapy. Hippokrates 1959;30:246-248.
[PubMed]
9.
Krauss H, Hartmann K: Studies on protein metabolism in therapeutic fasts. Arch Phys Ther (Leipz) 1964;16:109-122.
[PubMed]
10.
Owen OE, Smalley KJ, D'Alessio DA, Mozzoli MA, Dawson EK: Protein, fat, and carbohydrate requirements during starvation: anaplerosis and cataplerosis. Am J Clin Nutr 1998;68:12-34.
[PubMed]
11.
Varady KA, Hellerstein MK: Alternate-day fasting and chronic disease prevention: a review of human and animal trials. Am J Clin Nutr 2007;86:7-13.
[PubMed]
12.
Varady KA, Bhutani S, Church EC, Klempel MC: Short-term modified alternate-day fasting: a novel dietary strategy for weight loss and cardioprotection in obese adults. Am J Clin Nutr 2009;90:1138-1143.
[PubMed]
13.
Michalsen A: Prolonged fasting as a method of mood enhancement in chronic pain syndromes: a review of clinical evidence and mechanisms. Curr Pain Headache Rep 2010;14:80-87.
[PubMed]
14.
Wilhelmi de Toledo F, Buchinger A, Burggrabe H, et al.: Leitlinien zur Fastentherapie. Forsch Komplementärmed Klass Naturheilkd 2002;9:189-199.
15.
Fahrner H: Fasten als Therapie. Stuttgart, Hippokrates, 1991.
16.
Shelton H: The Hygienic System: Fasting and Sun Bathing. San Antonio, Dr. Shelton's Health School, 1963.
17.
Ramsey JJ, Colman RJ, Binkley NC, Christensen JD, Gresl TA, Kemnitz JW, Weindruch R: Dietary restriction and aging in rhesus monkeys: the University of Wisconsin study. Exp Gerontol 2000;35:1131-1149.
[PubMed]
18.
Fontana L, Partridge L, Longo VD: Extending healthy life span - from yeast to humans. Science 2010;328:321-326.
[PubMed]
19.
Holloszy JO: Mortality rate and longevity of food-restricted exercising male rats: a reevaluation. J Appl Physiol 1997;82:399-403.
[PubMed]
20.
Liebscher D: Auswirkungen religiösen Fastens auf anthropometrische Parameter, Blutfettwerte und Hämodynamik normalgewichtiger gesunder Probanden. Dissertation, Medizinische Fakultät Carl Gustav Carus, Technische Universität Dresden, 2012. www.qucosa.de/fileadmin/data/qucosa/documents/9629/Auswirkungen_religi%C3%B6sen_Fastens_auf_anthropometrische_Parameter,_Bluttfettwerte_und_H%C3%A4modynamik_normalgewichtiger_gesunder_Probanden.pdf (accessed on 05.12.2013).
21.
Varady KA, Roohk DJ, Loe YC, McEvoy-Hein BK, Hellerstein MK: Effects of modified alternate-day fasting regimens on adipocyte size, triglyceride metabolism, and plasma adiponectin levels in mice. J Lipid Res 2007;48:2212-2219.
[PubMed]
22.
Holzenberger M, Dupont J, Ducos B, Leneuve P, Geloen A, Even PC, Cervera P, Le Bouc Y: IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice. Nature 2003;421:182-187.
[PubMed]
23.
Merry BJ: Oxidative stress and mitochondrial function with aging - the effects of calorie restriction. Aging Cell 2004;3:7-12.
[PubMed]
24.
Kouda K, Iki M: Beneficial effects of mild stress (hormetic effects): dietary restriction and health. J Physiol Anthropol 2010;29:127-132.
[PubMed]
25.
Mattson MP: Dietary factors, hormesis and health. Ageing Research Reviews 2008;7:43-48.
[PubMed]
26.
Poljsak B: Strategies for reducing or preventing the generation of oxidative stress. Oxid Med Cell Longev 2011;2011:194586.
[PubMed]
27.
Varela A, Marina Prendes MG, Testoni G, Vazquez N, Astudilla C, Cerruti S, Savino EA: Influence of fasting on the effects of ischemic preconditioning in the ischemic-reperfused rat heart. Arch Physiol Biochem 2002;110:189-196.
[PubMed]
28.
Gredilla R, Sanz A, Lopez-Torres M, Barja G: Caloric restriction decreases mitochondrial free radical generation at complex I and lowers oxidative damage to mitochondrial DNA in the rat heart. FASEB J 2001;15:1589-1591.
[PubMed]
29.
Ristow M, Schmeisser S: Extending life span by increasing oxidative stress. Free Radic Biol Med 2011;51:327-336.
[PubMed]
30.
Varady KA, Ebine N, Vanstone CA, Parsons WE, Jones PJ: Plant sterols and endurance training combine to favorably alter plasma lipid profiles in previously sedentary hypercholesterolemic adults after 8 wk. Am J Clin Nutr 2004;80:1159-1166.
[PubMed]
31.
Hall JA, Dominy JE, Lee Y, Puigserver P: The sirtuin family's role in aging and age-associated pathologies. J Clin Invest 2013;123:973-979.
[PubMed]
32.
Choi AM, Ryter SW, Levine B: Autophagy in human health and disease. N Engl J Med 2013;368:651-662.
[PubMed]
33.
Kuma A, Hatano M, Matsui M, Yamamoto A, Nakaya H, Yoshimori T, Ohsumi Y, Tokuhisa T, Mizushima N: The role of autophagy during the early neonatal starvation period. Nature 2004;432:1032-1036.
[PubMed]
34.
Jia K, Levine B: Autophagy is required for dietary restriction-mediated life span extension in C. elegans. Autophagy 2007;3:597-599.
[PubMed]
35.
Sell DR: Ageing promotes the increase of early glycation Amadori product as assessed by epsilon-N-(2-furoylmethyl)-L-lysine (furosine) levels in rodent skin collagen. The relationship to dietary restriction and glycoxidation. Mech Ageing Dev 1997; 95:81-99.
[PubMed]
36.
Bierhaus A, Humpert PM, Stern DM, Arnold B, Nawroth PP: Advanced glycation end product receptor-mediated cellular dysfunction. Ann N Y Acad Sci 2005;1043:676-680.
[PubMed]
37.
Uribarri J, Cai W, Ramdas M, Goodman S, Pyzik R, Chen X, Zhu L, Striker GE, Vlassara H: Restriction of advanced glycation end products improves insulin resistance in human type 2 diabetes: potential role of AGER1 and SIRT1. Diabetes Care 2011;34:1610-1616.
[PubMed]
38.
Cai W, He JC, Zhu L, Chen X, Zheng F, Striker GE, Vlassara H: Oral glycotoxins determine the effects of calorie restriction on oxidant stress, age-related diseases, and lifespan. Am J Pathol 2008;173:327-336.
[PubMed]
39.
Iwashige K, Kouda K, Kouda M, Horiuchi K, Takahashi M, Nagano A, Tanaka T, Takeuchi H: Calorie restricted diet and urinary pentosidine in patients with rheumatoid arthritis. J Physiol Anthropol Appl Human Sci 2004;23:19-24.
[PubMed]
40.
Brecchia G, Bonanno A, Galeati G, Federici C, Maranesi M, Gobbetti A, Zerani M, Boiti C: Hormonal and metabolic adaptation to fasting: effects on the hypothalamic-pituitary-ovarian axis and reproductive performance of rabbit does. Domest Anim Endocrinol 2006;31:105-122.
[PubMed]
41.
Kim HG, Lim EY, Jung WR, Shin MK, Ann ES, Kim KL: Effects of treadmill exercise on hypoactivity of the hypothalamo-pituitary-adrenal axis induced by chronic administration of corticosterone in rats. Neurosci Lett 2008;434:46-49.
[PubMed]
42.
Park S, Sohn S, Kineman RD: Fasting-induced changes in the hypothalamic-pituitary-GH axis in the absence of GH expression: lessons from the spontaneous dwarf rat. J Endocrinol 2004;180:369-378.
[PubMed]
43.
Fekete C, Singru PS, Sanchez E, Sarkar S, Christoffolete MA, Riberio RS, Rand WM, Emerson CH, Bianco AC, Lechan RM: Differential effects of central leptin, insulin, or glucose administration during fasting on the hypothalamic-pituitary-thyroid axis and feeding-related neurons in the arcuate nucleus. Endocrinology 2006;147:520-529.
[PubMed]
44.
Shahab M, Zaman W, Bashir K, Arslan M: Fasting-induced suppression of hypothalamic-pituitary-gonadal axis in the adult rhesus monkey: evidence for involvement of excitatory amino acid neurotrans-mitters. Life Sci 1997;61:1293-1300.
[PubMed]
45.
Steiner J, LaPaglia N, Kirsteins L, Emanuele M, Emanuele N: The response of the hypothalamic-pituitary-gonadal axis to fasting is modulated by leptin. Endocr Res 2003;29:107-117.
[PubMed]
46.
Ahima RS, Prabakaran D, Mantzoros C, Qu D, Lowell B, Maratos-Flier E, Flier JS: Role of leptin in the neuroendocrine response to fasting. Nature 1996;382:250-252.
[PubMed]
47.
Silva J P, von Meyenn F, Howell J, Thorens B, Wolfrum C, Stoffel M: Regulation of adaptive behaviour during fasting by hypothalamic Foxa2. Nature 2009;462:646-650.
[PubMed]
48.
Goehler L, Hahnemann T, Michael N, Oehme P, Steglich HD, Conradi E, Grune T, Siems WG: Reduction of plasma catecholamines in humans during clinically controlled severe underfeeding. Prev Med 2000;30:95-102.
[PubMed]
49.
Palmblad J, Levi L, Burger A, Melander A, Westgren U, von Schenck H, Skude G: Effects of total energy withdrawal (fasting) on thelevels of growth hormone, thyrotropin, cortisol, adrenaline, noradrenaline, T4, T3, and rT3 in healthy males. Acta Med Scand 1977;201:15-22.
[PubMed]
50.
Bergendahl M, Vance ML, Iranmanesh A, Thorner MO, Veldhuis JD: Fasting as a metabolic stress paradigm selectively amplifies cortisol secretory burst mass and delays the time of maximal nyctohemeral cortisol concentrations in healthy men. J Clin Endocrinol Metab 1996;81:692-699.
[PubMed]
51.
Spark RF, Arky RA, Boulter PR, Saudek CD, O‘Brian JT: Renin, aldosterone and glucagon in the natriuresis of fasting. N Engl J Med 1975;292:1335-1340.
[PubMed]
52.
Maoz E, Shamiss A, Peleg E, Salzberg M, Rosenthal T: The role of atrial natriuretic peptide in natriuresis of fasting. J Hypertens 1992;10:1041-1044.
[PubMed]
53.
Michalsen A, Kuhlmann MK, Lüdtke R, Bäcker M, Langhorst J, Dobos GJ: Prolonged fasting in patients with chronic pain syndromes leads to late mood-enhancement not related to weight loss and fasting-induced leptin depletion. Nutr Neurosci 2006;9:195-200.
[PubMed]
54.
Horowitz JF, Coppack SW, Paramore D, Cryer PE, Zhao G, Klein S: Effects of short-term fasting on lipid kinetics in lean and obese woman. Am J Physiol 1999;276:E278-284.
[PubMed]
55.
Bergendahl M, Evans WS, Pastor C, Patel A, Iranmanesh A, Veldhuis JD: Short-term fasting suppresses leptin and (conversely) activates disorderly growth hormone secretion in midluteal phase women - a clinical research center study. J Clin Endocrinol Metab 1999;84:883-894.
[PubMed]
56.
Ahima RS, Lazar MA: Adipokines and the peripheral and neural control of energy balance. Mol Endocrinol 2008;22:1023-1031.
[PubMed]
57.
Schweiger U, Broocks A, Tuschl RJ, Pirke KM: Serotonin turnover in rat brain during semistarvation with high-protein and high-carbohydrate diets. J Neural Transm 1989;77:131-139.
[PubMed]
58.
Curzon G, Joseph MH, Knott PJ: Effects of immobilization and food deprivation on rat brain tryptophan metabolism. J Neurochem 1972;19:1967-1974.
[PubMed]
59.
Ishida A, Nakajima W, Takada G: Short-term fasting alters neonatal rat striatal dopamine levels and serotonin metabolism: an in vivo microdialysis study. Brain Res Dev Brain Res 1997;104:131-136.
[PubMed]
60.
Knott PJ, Joseph MH, Curzon G: Effects of food deprivation and immobilization on tryptophan and other amino acids in rat brain. J Neurochem 1973;20:249-251.
[PubMed]
61.
Huether G, Zhou D, Schmidt S, Wiltfang J, Ruther E: Long-term food restriction down-regulates the density of serotonin transporters in the rat frontal cortex. Biol Psychiatry 1997;41:1174-1180.
[PubMed]
62.
Lipecki R: Klinische Studie zur Effizienz einer kombinierten Heilfastenbehandlung als Migräne-therapie. Dissertation, Universität Würzburg, 1990, pp 1-53.
63.
Araya AV, Orellana X, Espinoza J: Evaluation of the effect of caloric restriction on serum BDNF in overweight and obese subjects: preliminary evidences. Endocrine 2008;33:300-304.
[PubMed]
64.
Fontan-Lozano A, Lopez-Lluch G, Delgado-Garcia JM, Navas P, Carrion AM: Molecular bases of caloric restriction regulation of neuronal synaptic plasticity. Mol Neurobiol 2008;38:167-177.
[PubMed]
65.
Stanek K, Gunstad J, Leahey T, Glickman E, Alexander T, Spitznagel MB, Juvancic Heltzel J, Murray L: Serum brain-derived neurotrophic factor is associated with reduced appetite in healthy older adults. J Nutr Health Aging 2008;12:183-185.
[PubMed]
66.
Mattson MP: The impact of dictary energy intake on cognitive aging. Front Aging Neurosci 2010;8:5.
[PubMed]
67.
Duan W, Guo Z, Jiang H, Ware M, Li XJ, Mattson MP: Dietary restriction normalizes glucose metabolism and BDNF levels, slows disease progression, and increases survival in huntingtin mutant mice. Proc Natl Acad Sci USA 2003;100:2911-2916.
[PubMed]
68.
Goggi J, Pullar IA, Carney SL, Bradford HF: Modulation of neurotransmitter release induced by brain-derived neurotrophic factor in rat brain striatal slices in vitro. Brain Res 2002;941:34-42.
[PubMed]
69.
Rumajogee P, Madeira A, Verge D, Hamon M, Miquel MC: Up-regulation of the neuronal serotoninergic phenotype in vitro: BDNF and cAMP share Trk B-dependent mechanisms. J Neurochem 2002;83:1525-1528.
[PubMed]
70.
Komaki G, Tamai H, Sumioki H, Mori T, Kobayashi N, Mori K, Mori S, Nakagawa T: Plasma beta-endorphin during fasting in man. Horm Res 1990;33:239-243.
[PubMed]
71.
Molina PE, Hashiguchi Y, Meijerink WJ, Naukam RJ, Boxer R, Abumrad NN: Modulation of endogenous opiate production: effect of fasting. Biochem Biophys Res Commun 1995;207:312-317.
[PubMed]
72.
Hanus L, Avraham Y, Ben-Shushan D, Zolotarev O, Berry EM, Mechoulam R: Short-term fasting and prolonged semistarvation have opposite effects on 2-AG levels in mouse brain. Brain Res 2003;983:144-151.
[PubMed]
73.
Brown AJ: Low-carb diets, fasting and euphoria: Is there a link between ketosis and gamma-hydroxy-butyrate (GHB)? Med Hypotheses 2007;68:268-271.
[PubMed]
74.
Maalouf M, Rho JM, Mattson MP: The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies. Brain Res Rev 2009; 59:293-315.
[PubMed]
75.
White AM, Johnston CS, Swan PD, Tjonn SL, Sears B: Blood ketones are directly related to fatigue and perceived effort during exercise in overweight adults adhering to low-carbohydrate diets for weight loss: a pilot study. J Am Diet Assoc 2007;107:1792-1796.
[PubMed]
76.
Gasior M, French A, Joy MT, Tang RS, Hartman AL, Rogawski MA: The anticonvulsant activity of acetone, the major ketone body in the ketogenic diet, is not dependent on its metabolites acetol, 1,2-propanediol, methylglyoxal, or pyruvic acid. Epilepsia 2007;48:793-800.
[PubMed]
77.
Hasebe N, Abe K, Sugiyama E, Hosoi R, Inoue O: Anticonvulsant effects of methyl ethyl ketone and diethyl ketone in several types of mouse seizure models. Eur J Pharmacol 2010;642:66-71.
[PubMed]
78.
Likhodii SS, Serbanescu I, Cortez MA, Murphy P, Snead OC 3rd, Burnham WM: Anticonvulsant properties of acetone, a brain ketone elevated by the ketogenic diet. Ann Neurol 2003;54:219-226.
[PubMed]
79.
Zarnowska I, Luszczki JJ, Zarnowski T, Buszewicz G, Madro R, Czuczwar SJ, Gasior M: Pharmacodynamic and pharmacokinetic interactions between common antiepileptic drugs and acetone, the chief anticonvulsant ketone body elevated in the ketogenic diet in mice. Epilepsia 2009;50:1132-1140.
[PubMed]
80.
Stafstrom CE, Rho JM: The ketogenic diet as a treatment paradigm for diverse neurological disorders. Front Pharmacol 2012;3:59.
[PubMed]
81.
Darlington LG, Ramsey NW, Mansfield JR: Placebo-controlled, blind study of dietary manipulation therapy in rheumatoid arthritis. Lancet 1986;1:236-238.
[PubMed]
82.
Sköldstam L, Larsson L, Lindström FD: Effect of fasting and lactovegetarian diet on rheumatoid arthritis. Scand J Rheumatol 1979;8:249-255.
[PubMed]
83.
Uden AM, Trang L, Venizelos N, Palmblad J: Neutrophil functions and clinical performance after total fasting in patients with rheumatoid arthritis. Ann Rheum Dis 1983;42:45-51.
[PubMed]
84.
Hafstrom I, Ringertz B, Gyllenhammar H, Palmblad J, Harms-Ringdahl M: Effects of fasting on disease activity, neutrophil function, fatty acid composition, and leukotriene biosynthesis in patients with rheumatoid arthritis. Arthritis Rheum 1988;31:585-592.
[PubMed]
85.
Kjeldsen-Kragh J, Haugen M, Borchgrevink CF, Laerum E, Eek M, Mowinkel P, Hovi K, Forre O: Controlled trial of fasting and one-year vegetarian diet in rheumatoid arthritis. Lancet 1991;338:899-902.
[PubMed]
86.
Müller H, Wilhelmi de Toledo F, Resch KL: Fasting followed by vegetarian diet in patients with rheumatoid arthritis: a systematic review. Scand J Rheumatol 2001;30:1-10.
[PubMed]
87.
Schmidt S, Stange R, Lischka E, Kiehntopf M, Deufel T, Loth D, Uhlemann C: Uncontrolled clinical study of the efficacy of ambulant fasting in patients with osteoarthritis. Forsch Komplementmed 2010;17:87-94.
[PubMed]
88.
Hargraves WA, Hentall ID: Analgesic effects of dietary caloric restriction in adult mice. Pain 2005;114:455-461.
[PubMed]
89.
de los Santos-Arteaga M, Sierra-Dominguez SA, Fontanella GH, Delgado-Garcia JM, Carrion AM: Analgesia induced by dietary restriction is mediated by the kappa-opioid system. J Neurosci 2003;23:11120-11126.
[PubMed]
90.
Michalsen A, Schneider S, Rodenbeck A, Lüdtke R, Huether G, Dobos GJ: The short-term effects of fasting on the neuroendocrine system in patients with chronic pain syndromes. Nutr Neurosci 2003;6:11-18.
[PubMed]
91.
Michalsen A, Riegert M, Lüdtke R, Bäcker M, Langhorst J, Schwickert M, Dobos GJ: Mediterranean diet or extended fasting's influence on changing the intestinal microflora, immunoglobulin A secretion and clinical outcome in patients with rheumatoid arthritis and fibromyalgia: an observational study. BMC Complement Altern Med 2005;5:22.
[PubMed]
92.
Michalsen A, Li C, Kaiser K, Lüdtke R, Meier L, Stange R, Kessler C: In-patient treatment of fibromyalgia: a controlled nonrandomized comparison of conventional medicine versus integrative medicine including fasting therapy. Evid Based Complement Alternat Med 2013;2013:908610.
[PubMed]
93.
Michalsen A, Hoffmann B, Moebus S, Bäcker M, Langhorst J, Dobos GJ: Incorporation of fasting therapy in an integrative medicine ward: evaluation of outcome, safety, and effects on lifestyle adherence in a large prospective cohort study. J Altern Complement Med 2005;11:601-607.
[PubMed]
94.
Goldhamer AC, Lisle DJ, Sultana P, Anderson SV, Parpia B, Hughes B, Campbell TC: Medically supervised water-only fasting in the treatment of borderline hypertension. J Altern Complement Med 2002; 8:643-650.
[PubMed]
95.
Schwartz MW, Seeley RJ: Seminars in medicine of the Beth Israel Deaconess Medical Center. Neuroendocrine responses to starvation and weight loss. N Engl J Med 1997;336:1802-1811.
[PubMed]
96.
Müller H, Wilhelmi de Toledo F, Schuck P, Resch KL: Blutdrucksenkung durch Fasten bei adipösen und nichtadipösen Hypertonikern. Perfusion 2001;14:108-112.
97.
Dessi-Fulgheri P, Sarzani R, Serenelli M, Tamburrini P, Spagnolo D, Giantomassi L, Espinosa E, Rappelli A: Low calorie diet enhances renal, hemodynamic, and humoral effects of exogenous atrial natriuretic peptide in obese hypertensives. Hypertension 1999;33:658-662.
[PubMed]
98.
Goldhamer AC: Initial cost of care results in medically supervised water-only fasting for treating high blood pressure and diabetes. J Altern Complement Med 2002;8:696-697.
[PubMed]
99.
Goldhamer A, Lisle D, Parpia B, Anderson SV, Campbell TC: Medically supervised water-only fasting in the treatment of hypertension. J Manipulative Physiol Ther 2001;24:335-339.
[PubMed]
100.
Schubmann R, Graban I, Hölz G, Zwingmann C: Ergebnisqualität stationärer Rehabilitation bei Patienten mit Adipositas. Deutsche Rentenversicherung 1997;9-10:1-22.
101.
Horne BD, May HT, Anderson JL, Kfoury AG, Bailey BM, McClure BS, Renlund DG, Lappe DL, Carlquist JF, Fisher PW, Pearson RR, Bair TL, Adams TD, Muhlestein JB; Intermountain Heart Collaborative Study: Usefulness of routine periodic fasting to lower risk of coronary artery disease in patients undergoing coronary angiography. Am J Cardiol 2008;102:814-819.
[PubMed]
102.
Ahmet I, Wan R, Mattson M P, Lakatta EG, Talan MI: Chronic alternate-day fasting results in reduced diastolic compliance and diminished systolic reserve in rats. J Card Fail 2010;16:843-853.
[PubMed]
103.
Watts NB, DiGirolamo M: Carbohydrate tolerance improves with fasting in obese subjects with noninsulin-dependent (type II) diabetes. Am J Med Sci 1990;299:250-256.
[PubMed]
104.
Li C, Ostermann T, Hardt M, Lüdtke R, Broecker-Preuss M, Dobos G, Michalsen A: Metabolic and psychological response to 7-day fasting in obese patients with and without metabolic syndrome. Forsch Komplementmed 2013;20:413-420.
105.
Stange R, Pflugbeil C, Michalsen A, Uehleke B: Therapeutic fasting in patients with metabolic syndrome and impaired insulin resistance. Forsch Komplementmed 2013;20:421-426.
106.
Raffaghello L, Lee C, Safdie FM, Wei M, Madia F, Bianchi G, Longo VD: Starvation-dependent differential stress resistance protects normal but not cancer cells against high-dose chemotherapy. Proc Natl Acad Sci USA 2008;105:8215-8220.
[PubMed]
107.
Lee C, Longo VD: Fasting vs dietary restriction in cellular protection and cancer treatment: from model organisms to patients. Oncogene 2011;30:3305-3316.
[PubMed]
108.
Lee C, Raffaghello L, Brandhorst S, Safdie FM, Bianchi G, Martin-Montalvo A, Pistoia V, Wei M, Hwang S, Merlino A, Emionite L, de Cabo R, Longo VD: Fasting cycles retard growth of tumors and sensitize a range of cancer cell types to chemo therapy. Sci Transl Med 2012;4:124ra127.
[PubMed]
109.
Lee C, Safdie FM, Raffaghello L, Wei M, Madia F, Parrella E, Hwang D, Cohen P, Bianchi G, Longo VD: Reduced levels of IGF-I mediate differential protection of normal and cancer cells in response to fasting and improve chemotherapeutic index. Cancer Res 2010;70:1564-1572.
[PubMed]
110.
Brandhorst S, Wei M, Hwang S, Morgan TE, Longo VD: Short-term calorie and protein restriction provide partial protection from chemotoxicity but do not delay glioma progression. Exp Gerontol 2013;48:1120-1128.
[PubMed]
111.
Safdie FM, Dorff T, Quinn D, Fontana L, Wei M, Lee C, Cohen P, Longo VD: Fasting and cancer treatment in humans: a case series report. Aging 2009;1:988-1007.
[PubMed]
112.
Michalsen A: Stressed patients, stressed physicians and the need for mind-body medicine. Forsch Komplementmed 2010;17:237-239.
[PubMed]
113.
Michalsen A, Frey UH, Merse S, Siffert W, Dobos GJ: Hunger and mood during extended fasting are dependent on the GNB3 C825T polymorphism. Ann Nutr Metab 2009;54:184-188.
[PubMed]
114.
Michalsen A, Weidenhammer W, Melchart D, Langhorst J, Saha J, Dobos G: Short-term therapeutic fasting in the treatment of chronic pain and fatigue syndromes - well-being and side effects with and without mineral supplements. Forsch Komplementärmed Klass Naturheilkd 2002;9:221-227.
[PubMed]
115.
Roky R, Houti I, Moussamih S, Qotbi S, Aadil N: Physiological and chronobiological changes during Ramadan intermittent fasting. Ann Nutr Metab 2004;48:296-303.
[PubMed]
116.
Hussin NM, Shahar S, Teng NI, Ngah WZ, Das SK: Efficacy of fasting and calorie restriction (FCR) on mood and depression among ageing men. J Nutr Health Aging 2013;17:674-680.
[PubMed]
117.
Wilhelmi de Toledo F, Friebe R, Hebisch D et al. : The Klinik Buchinger Programme for the treatment of obesity; in Ditschuneit H, Gries FA, Hautner H, et al. (eds): Obesity in Europe 1993. London, Libbey, 1994, pp 289-293.
118.
Kanazawa M, Fukudo S: Effects of fasting therapy on irritable bowel syndrome. Int J Behav Med 2006;13:214-220.
[PubMed]
119.
Schubmann R: Therapeutisches Fasten bei Adipositas und metabolischem Syndrom. Zeitschrift für Komplementärmedizin 2009;1:14-17.
120.
Peper E: Evaluation der Effekte und Erfolge von stationären Heilfastenmassnahmen. Frankfurt/M., Lang, 1999.
121.
Isner JM, Sours HE, Paris AL, Ferrans VJ, Roberts WC: Sudden, unexpected death in avid dieters using the liquid-protein-modified-fast diet. Observations in 17 patients and the role of the prolonged QT interval. Circulation 1979;60:1401-1412.
[PubMed]
122.
Spencer IO: Death during therapeutic starvation for obesity. Lancet 1968;1:1288-1290.
[PubMed]
123.
Frattali VP: Deaths associated with the liquid protein diet. Bull Natl Clgh Poison Control Cent 1979;23:4-11.
[PubMed]
124.
Hearing SD: Refeeding syndrome. BMJ 2004;328:908-909.
[PubMed]
125.
Wilhelmi de Toledo F, Buchinger A, Gaisbauer M, et al.: Fasting therapy - a revised expert panel update of the 2002 consensus guidelines. Forsch Komplementmed 2013;20:444-453.
© 2014 S. Karger GmbH, Freiburg
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2013
You do not currently have access to this content.
